Esperion Therapeutics Statistics

Total Valuation

ESPR has a market cap or net worth of $816.06 million. The enterprise value is $1.20 billion.

Market Cap	816.06M
Enterprise Value	1.20B

Important Dates

The next estimated earnings date is Tuesday, August 4, 2026, before market open.

Earnings Date	Aug 4, 2026
Ex-Dividend Date	n/a

Share Statistics

ESPR has 257.43 million shares outstanding. The number of shares has increased by 14.32% in one year.

Current Share Class	257.43M
Shares Outstanding	257.43M
Shares Change (YoY)	+14.32%
Shares Change (QoQ)	-11.67%
Owned by Insiders (%)	0.87%
Owned by Institutions (%)	68.27%
Float	234.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.95
Forward PS	2.25
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.88
EV / EBITDA	15.86
EV / EBIT	15.88
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.53

Current Ratio	1.53
Quick Ratio	0.96
Debt / Equity	n/a
Debt / EBITDA	6.94
Debt / FCF	n/a
Interest Coverage	0.89

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	23.47%
Return on Capital Employed (ROCE)	46.73%
Weighted Average Cost of Capital (WACC)	11.01%
Revenue Per Employee	$1.42M
Profits Per Employee	-$25,248
Employee Count	294
Asset Turnover	1.06
Inventory Turnover	1.37

Taxes

In the past 12 months, ESPR has paid $1.84 million in taxes.

Income Tax	1.84M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +213.86% in the last 52 weeks. The beta is 1.07, so ESPR's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	+213.86%
50-Day Moving Average	2.88
200-Day Moving Average	3.03
Relative Strength Index (RSI)	68.77
Average Volume (20 Days)	11,278,052

Short Selling Information

The latest short interest is 18.71 million, so 7.27% of the outstanding shares have been sold short.

Short Interest	18.71M
Short Previous Month	20.21M
Short % of Shares Out	7.27%
Short % of Float	7.99%
Short Ratio (days to cover)	0.95

Income Statement

In the last 12 months, ESPR had revenue of $418.24 million and -$7.42 million in losses. Loss per share was -$0.03.

Revenue	418.24M
Gross Profit	241.70M
Operating Income	75.79M
Pretax Income	-5.58M
Net Income	-7.42M
EBITDA	75.89M
EBIT	75.79M
Loss Per Share	-$0.03

Full Income Statement

Balance Sheet

The company has $156.16 million in cash and $543.81 million in debt, giving a net cash position of -$387.65 million or -$1.51 per share.

Cash & Cash Equivalents	156.16M
Total Debt	543.81M
Net Cash	-387.65M
Net Cash Per Share	-$1.51
Equity (Book Value)	-307.93M
Book Value Per Share	-1.20
Working Capital	159.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.19 million and capital expenditures -$189,000, giving a free cash flow of -$18.38 million.

Operating Cash Flow	-18.19M
Capital Expenditures	-189,000
Depreciation & Amortization	106,000
Net Borrowing	-54.91M
Free Cash Flow	-18.38M
FCF Per Share	-$0.07

Full Cash Flow Statement

Margins

Gross margin is 57.79%, with operating and profit margins of 18.12% and -1.77%.

Gross Margin	57.79%
Operating Margin	18.12%
Pretax Margin	-1.33%
Profit Margin	-1.77%
EBITDA Margin	18.15%
EBIT Margin	18.12%
FCF Margin	n/a

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.32%
Shareholder Yield	-14.32%
Earnings Yield	-0.91%
FCF Yield	-2.25%

Analyst Forecast

The average price target for ESPR is $3.19, which is 0.63% higher than the current price. The consensus rating is "Hold".

Price Target	$3.19
Price Target Difference	0.63%
Analyst Consensus	Hold
Analyst Count	6
Revenue Growth Forecast (3Y)	12.04%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ESPR has an Altman Z-Score of -2.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.72
Piotroski F-Score	5